Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy

International Journal of Medical Sciences - Canada
doi 10.7150/ijms.42805
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Inhibitor of DNA Binding 1 (Id1) Mediates Stemness of Colorectal Cancer Cells Through the Id1-C-Myc-Plac8 Axis via the WNT/Β-Catenin and SHH Signaling Pathways

Cancer Management and Research
Oncology
2019English

Inhibitor of Differentiation-1 (Id1) Sustains Mutant KRAS-driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network

Cancer Research
Cancer ResearchOncology
2018English

Tissue Inhibitor of Metalloproteinases-1 in Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2005English

Inhibitor of DNA Binding 1 (ID1); VEGF Receptor 2 (KDR/Flk-1; VEGFR-2)

Science-Business eXchange
2010English

Differentiation Therapy: A Promising Strategy for Cancer Treatment

Chinese Journal of Cancer
2016English

Cancer Therapy Combination: Green Tea and a Phosphodiesterase 5 Inhibitor?

Journal of Clinical Investigation
Medicine
2013English

Novel COX-2 Inhibitor for Breast Cancer Therapy

2003English

A PARP Inhibitor in Pancreatic Cancer: Enhancement Anti-Tumour Activity of Chemoradiation Therapy Against Pancreatic Cancer?

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer With Low Xist Expression

Clinical Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy